Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
191 hedge funds and large institutions have $568M invested in Immunogen Inc in 2019 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 59 increasing their positions, 58 reducing their positions, and 30 closing their positions.
247% more call options, than puts
Call options by funds: $2.7M | Put options by funds: $777K
126% more capital invested
Capital invested by funds: $252M → $568M (+$316M)
10% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 30
1% more funds holding
Funds holding: 189 → 191 (+2)
2% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 58
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$7.41M |
| 2 |
Morgan Stanley
New York
|
+$5.72M |
| 3 |
D.E. Shaw & Co
New York
|
+$4.29M |
| 4 |
Millennium Management
New York
|
+$3.55M |
| 5 |
Two Sigma Investments
New York
|
+$2.77M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ClearBridge Investments
New York
|
-$4.46M |
| 2 |
State Street
Boston,
Massachusetts
|
-$2.93M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.44M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.08M |
| 5 |
Squarepoint
New York
|
-$1.07M |
IMGN Hedge Fund Activity: Q4 2019 in Review
191 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q4 2019, worth a combined $568M — up 126% from $252M a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new IMGN positions and 30 closed out — a net gain of 3 holders — while 59 added to existing stakes and 58 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $7.41M. The largest seller was ClearBridge Investments, cutting an estimated $4.46M.
- 191 institutional investors held Immunogen Inc (IMGN) as of Q4 2019, up from 189 in Q3 2019.
- Funds reported $568M of Immunogen Inc stock for Q4 2019, up 126% quarter-over-quarter.
- 33 funds opened new Immunogen Inc positions in Q4 2019 and 30 closed out, a net change of +3 holders.
- The largest Immunogen Inc buyer in Q4 2019 was Renaissance Technologies, an estimated $7.41M added.
- The largest Immunogen Inc seller in Q4 2019 was ClearBridge Investments, an estimated $4.46M sold.
Based on aggregated 13F filings for Q4 2019.